Drawing for ZEAL&

USPTO serial 86841976

ZEAL&

Reviewed by CopyMark Law Group

Reg. 6443757Status 700Renewal
Filing date
Status date
Registration date
Aug 10, 2021
Examiner
TRATOS, MARK STEVEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZEAL&?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebecca A. Liebowitz

Rebecca A. Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; peptide substrates used in analyzing and detecting certain toxins for laboratory or research useACTIVE—
005Pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans, namely, pharmaceutical preparations for treating endocrine disorders, immunity disorders, nutritional and metabolic diseases, such as diabetes and obesity, pharmaceutical preparations for the treatment and prevention of hypoglycemia; antihypoglycemic agents, medical preparations in the nature of a liquid solution for medical purposes for the treatment and prevention of hypoglycemia; pharmaceutical preparations for treating gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; pharmaceutical preparations altering the immune system, such as complement inhibitors; none of the forgoing including vitamins, mineral herbal supplements, dietary supplements or food supplements and none of the forgoing including drugs for the treatment of arthrosis, polyarthrosis, spondylarthrosis or scapulohumeral periarthritisACTIVE—
035Exploitation of scientific research and technology, namely, promoting collaboration and the exchange of information and resources within the scientific, research and medical communities to achieve advances in the field of health careACTIVE—
044Medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 10, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 23, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 4, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 3, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 10, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 25, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 25, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2021FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 16, 2021ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 9, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 27, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 26, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 26, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 14, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 6, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 6, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Mar 6, 2017CNSLSUSPENSION LETTER WRITTEN—
Feb 13, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 13, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2017ALIEASSIGNED TO LIE—
Dec 29, 2016EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 30, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 30, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Sep 30, 2016CNSLSUSPENSION LETTER WRITTEN—
Sep 16, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2016EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 30, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2016DOCKASSIGNED TO EXAMINER—
Dec 12, 2015MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 11, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance